Adaptive Biotechnologies (ADPT) has priced its private offering of senior unsecured convertible notes due 2031. Due to strong institutional demand, the aggregate principal amount of the offering was ...
Proceeds expected to be deployed to repay the OrbiMed Purchase Agreement to enhance financial flexibility Additional proceeds used to pay for the ...
Bandwidth (BAND) has intended to offer and sell $275M aggregate principal amount of convertible senior notes due 2032 in a private placement, with an option for the initial purchasers to buy an ...
Bandwidth Inc. (NASDAQ: BAND) ("Bandwidth"), a leading global cloud communications company, today announced the pricing of $275 million aggregate principal amount of 0% Convertible Senior Notes due ...
Bandwidth (BAND) prices $275M 0% convertible notes due 2032; proceeds fund capped calls, buybacks and debt repayment.
Refinancing transaction with proceeds to be utilized to repurchase or repay the 2026 convertible notes prior to or at maturity - - Offering made at 0% interest with ...
Ciena ® Corporation (NYSE: CIEN) (the "Company"), the global leader in high-speed connectivity, today announced that it intends to offer $2.0 billion aggregate principal amount of convertible senior ...
Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter. NeoGenomics ( (NEO)) just unveiled an announcement. On June 17, 2026, NeoGenomics announced the ...
NeoGenomics ( (NEO)) has issued an announcement. On June 15, 2026, NeoGenomics announced it had commenced a private offering of $275 million in convertible senior notes due 2032, targeted at qualified ...
LOS ANGELES, Oct. 8, 2025 /PRNewswire/ -- Live Nation Entertainment, Inc. (LYV) (the "company") today announced that it intends to offer, subject to market and other conditions, $1.3 billion in ...
(RTTNews) - Mirion Technologies Inc. (MIR) announced the pricing of $325.0 million aggregate principal amount of 0.00% Convertible Senior Notes due 2031 in a private placement. The size of the ...
PTC Therapeutics, Inc., (NASDAQ: PTCT) today announced that it intends to offer, subject to market conditions and other factors, $500.0 million aggregate principal amount of Convertible Senior Notes ...